Jobs / United States / Regeneron Pharmaceuticals INC
Director, Tax Operations
Regeneron Pharmaceuticals INC · 🇺🇸 SLEEPY HOLLOW
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 290 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 40 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Regeneron Pharmaceuticals INC paid sponsored hires in similar roles6 certified filings for “Director IT Operations Management” (Computer and Information Systems Managers) in NJ: $220k–$263k, median $236k. Most were filed at wage level II (50%) — 2 lottery entries, ≈31% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Regeneron Pharmaceuticals INC
The US Department of Labor certified 290 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 40 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Regeneron Pharmaceuticals INC →
About the role
Build Our Future Together At Regeneron, we use science and innovation to develop life-changing medicines for people with serious diseases. We are seeking a Director of Tax Operations to own the day-to-day management of the company's global tax reporting and compliance functions for the US. Reporting to the Head of Tax Operations, the Director runs the operational execution of tax accounting (ASC 740), U.S. compliance, indirect taxes, SOX controls, audits, and the systems and data that support them. In this role you will modernize the tax operating model — embedding artificial intelligence (AI), automation, and analytics into everyday tax work while maintaining rigorous controls and human review. The Director coordinates with Tax Strategy counterparts on planning, technical positions, and shared or cross-functional work, and manages the U.S. and Ireland operations as a single, well-run team. When & Where: This position is full-time and will sit in our Sleepy Hollow, NY office four days per week. Discovery Your Role: • Manage ASC 740 tax accounting including provisions, reconciliations, financial statement disclosures, and external audit coordination • Ensure SOX-compliant internal controls over tax reporting processes, including AI and automation-enabled workflows • Oversee all U.S. federal, state, and international tax compliance, filings, payments, and audit-ready documentation • Manage tax credits (R&D, orphan drug), indirect taxes (sales/use, property, excise), and tax audits/examinations • Monitor and implement regulatory changes including OECD Pillar Two, U.S. CAMT, and international statutory requirements • Lead tax operations AI strategy by identifying use cases, piloting solutions, and establishing responsible-use guardrails • Own tax technology platforms, analytics tools, and data initiatives while driving process transformation and team upskilling • Partner with Tax Strategy and cross-functional stakeholders while leading and developing the Tax Operations team This Role Requires: • Bachelor's Degree in Tax, Accounting, Finance, or a related field plus at least 10 years of progressive corporate tax experience (or equivalent combination of education and professional experience) working for or with publicly traded, multinational companies; a combination of Big 4 and in-house experience is strongly preferred. • Deep expertise in ASC 740, including provisions, uncertain tax positions, financial statement disclosures, and strong U.S. federal and state income tax experience, with exposure to indirect taxes. • Life sciences or biopharmaceutical industry experience nice to have. • International and statutory reporting experience (FRS 102, IFRS); Ireland experience a plus nice to have. • Familiarity with the OECD global minimum tax (Pillar Two) and the U.S. corporate alternative minimum tax (CAMT) nice to have. • Experience leading tax technology, automation, or data-analytics initiatives nice to have. Does this sound like you? Apply now to take your first step towards living the Regeneron Way! We are committed to building a workplace with an inclusive culture. Regeneron is an equal opportunity employer and all qualified applicants will receive consideration for employment without regard to race, color, religion or belief (or lack thereof), sex, sexual orientation, gender identity or expression, gender reassignment, marital or civil partnership status, civil status, pregnancy or parental status, age, disability, nationality, citizenship status, ethnic or national origin, membership of the Traveler community, familial status, genetic information, military or veteran status, or any other characteristic protected under applicable law. Where required, we will provide reasonable accommodation to applicants with known